Carthera Funding Round

12/11/2023

Venture Equity

$4,850,000

Undisclosed

The funding will support the company in launching its first registrational trial using its SonoCloud technology in the treatment of recurrent glioblastoma (rGBM).

Private & Independent

Medical Devices & Instruments

50 Milk Street, 16th Floor,
Boston, MA 02109
USA

Undisclosed

Carthera® is a spin-off from AP-HP, Greater Paris University Hospitals, the largest hospital group in Europe, and Sorbonne University. The company leverages the inventions of Professor Alexandre Carpentier, lead neurosurgeon at AP-HP, who has achieved worldwide recognition for his breakthrough developments in treating brain tumors. Founded in 2010, Carthera® is headquartered at the Brain Institute (Institut du Cerveau, ICM) in Paris, with offices at the Bioparc Laennec business incubator in Lyon and a US subsidiary based in Boston. The company, led by Frederic Sottilini (CEO), works closely with renowned academic institutions in its field, like INSERM, Sorbonne University, AP-HP, Northwestern University, MD Anderson Cancer Center.